AIM ImmunoTech Inc (AIM) Has Recovered -14.29% From Its Low: Is This The Beginning Of A Trend?

AIM ImmunoTech Inc (AMEX:AIM) price on Wednesday, February 05, fall -20.88% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $0.14.

A look at the stock’s price movement, the close in the last trading session was $0.18, moving within a range at $0.131 and $0.18. The beta value (5-Year monthly) was -0.363. Turning to its 52-week performance, $0.62 and $0.16 were the 52-week high and 52-week low respectively. Overall, AIM moved -38.97% over the past month.

AIM ImmunoTech Inc’s market cap currently stands at around $9.80 million, with investors looking forward to this quarter’s earnings report slated for in March.

Analysts have a consensus estimate of 100k for the company’s revenue for the quarter, with a low and high estimate of 100k and 100k respectively. The average forecast suggests up to a 53.85% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 200k, representing a -0.99% decline on that reported in the last financial year.

Turning to the stock’s technical picture we see that short term indicators suggest on average that AIM is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.

1 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 1 recommend AIM as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.

AIM’s current price about -29.92% and -31.52% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 26.16, while 7-day volatility ratio is 14.54% and 10.74% in the 30-day chart. Further, AIM ImmunoTech Inc (AIM) has a beta value of 0.37, and an average true range (ATR) of 0.02.

If we refocus on AIM ImmunoTech Inc (AMEX:AIM), historical trading data shows that trading volumes averaged 0.83 over the past 10 days and 662.59K over the past 3 months. The company’s latest data on shares outstanding shows there are 68.75 million shares.

The 11.89% of AIM ImmunoTech Inc’s shares are in the hands of company insiders while institutional holders own 13.14% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 0.49 million on 2024-10-31, giving us a short ratio of 1.63. The data shows that as of 2024-10-31 short interest in AIM ImmunoTech Inc (AIM) stood at 85.00000000000001 of shares outstanding, with shares short falling to 0.59 million registered in 2024-09-30. Current price change has pushed the stock -28.03% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the AIM stock continues to rise going into the next quarter.

Most Popular